Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for Apyx Medical (APYX) over the last 4 years, with Q4 2024 value amounting to $1.1 million.

  • Apyx Medical's Gains from Sales and Divestitures changed N/A to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • Apyx Medical's Gains from Sales and Divestitures amounted to $1.1 million in Q4 2024.
  • In the past 5 years, Apyx Medical's Gains from Sales and Divestitures registered a high of $1.1 million during Q4 2024, and its lowest value of $1.1 million during Q4 2024.